Marshall Wace’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Hold |
182,190
| – | – | ﹤0.01% | 1530 |
|
|
2025
Q1 | $1.56M | Buy |
182,190
+41,071
| +29% | +$352K | ﹤0.01% | 1483 |
|
|
2024
Q4 | $1.52M | Buy |
+141,119
| New | +$1.52M | ﹤0.01% | 1438 |
|
|
2024
Q3 | – | Sell |
-39,351
| Closed | -$166K | – | 2296 |
|
|
2024
Q2 | $166K | Buy |
+39,351
| New | +$166K | ﹤0.01% | 2121 |
|
|
2023
Q4 | – | Sell |
-156,078
| Closed | -$1.02M | – | 1840 |
|
|
2023
Q3 | $1.02M | Buy |
156,078
+144,779
| +1,281% | +$948K | ﹤0.01% | 1263 |
|
|
2023
Q2 | $91.9K | Sell |
11,299
-36,401
| -76% | -$296K | ﹤0.01% | 1888 |
|
|
2023
Q1 | $409K | Buy |
47,700
+12,704
| +36% | +$109K | ﹤0.01% | 1718 |
|
|
2022
Q4 | $324K | Buy |
+34,996
| New | +$324K | ﹤0.01% | 1953 |
|
|
2022
Q3 | – | Sell |
-423,636
| Closed | -$4.24M | – | 2551 |
|
|
2022
Q2 | $4.24M | Buy |
423,636
+378,278
| +834% | +$3.79M | 0.01% | 1279 |
|
|
2022
Q1 | $558K | Buy |
+45,358
| New | +$558K | ﹤0.01% | 2066 |
|
|
2021
Q2 | – | Sell |
-163,087
| Closed | -$2.44M | – | 2098 |
|
|
2021
Q1 | $2.44M | Buy |
+163,087
| New | +$2.44M | 0.01% | 1059 |
|